Cosmetic cross-reference Noindex: medium evidence

Pyrithione Sodium

CAS 3811-73-2

Pyrithione Sodium (CAS 3811-73-2) is a pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
0
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Pyrithione Sodium
CAS Number
3811-73-2
UNII
6L3991491R
InChIKey
WNGMMIYXPIAYOB-UHFFFAOYSA-M
ChEMBL ID
CHEMBL2364542
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Pyrithione Sodium used for in pharmaceutical contexts?

Pyrithione Sodium (CAS 3811-73-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Pyrithione Sodium?

No adverse-event association or SIDER side-effect rows are rendered for Pyrithione Sodium in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Pyrithione Sodium also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Sodium Pyrithione with EU status "prohibited".

What clinical phase is Pyrithione Sodium in?

No phase 1-4 clinical development badge is rendered for Pyrithione Sodium because the matched compound identifier rows do not contain a max-phase value.